Item Type |
Article |
ID |
|
Preview |
Image |
|
Caption |
|
|
Full text |
KAKEN_24791718seika.pdf
Type |
:application/pdf |
Download
|
Size |
:242.5 KB
|
Last updated |
:Apr 11, 2016 |
Downloads |
: 680 |
Total downloads since Apr 11, 2016 : 680
|
|
Release Date |
|
Title |
Title |
子宮体癌におけるmiRNA治療薬の開発および診断への応用
|
Kana |
シキュウタイガン ニ オケル miRNA チリョウヤク ノ カイハツ オヨビ シンダン エノ オウヨウ
|
Romanization |
Shikyutaigan ni okeru miRNA chiryoyaku no kaihatsu oyobi shindan eno oyo
|
|
Other Title |
Title |
Application to the development and diagnosis of miRNA therapeutic agent in endometrial cancer
|
Kana |
|
Romanization |
|
|
Creator |
Name |
矢野倉, 恵
|
Kana |
ヤノクラ, メグミ
|
Romanization |
Yanokura, Megumi
|
Affiliation |
慶應義塾大学・医学部・特任助教
|
Affiliation (Translated) |
|
Role |
Research team head
|
Link |
科研費研究者番号 : 20433732
|
|
Edition |
|
Place |
|
Publisher |
|
Date |
Issued (from:yyyy) |
2015
|
Issued (to:yyyy) |
|
Created (yyyy-mm-dd) |
|
Updated (yyyy-mm-dd) |
|
Captured (yyyy-mm-dd) |
|
|
Physical description |
|
Source Title |
Name |
科学研究費補助金研究成果報告書
|
Name (Translated) |
|
Volume |
|
Issue |
|
Year |
2014
|
Month |
|
Start page |
|
End page |
|
|
ISSN |
|
ISBN |
|
DOI |
|
URI |
|
JaLCDOI |
|
NII Article ID |
|
Ichushi ID |
|
Other ID |
|
Doctoral dissertation |
Dissertation Number |
|
Date of granted |
|
Degree name |
|
Degree grantor |
|
|
Abstract |
microRNAは, 癌の発症・進展・薬剤耐性とも大きく関わることが明らかになっている。我々は, 子宮体癌においてエピジェネティックに発現抑制される癌抑制型microRNAとしてmiR-34bを同定し, さらにmiR-34bと抗癌剤の併用による抗腫瘍効果を検討した。
3種の子宮体癌細胞株に対しパクリタキセルを作用させた時は, 全ての細胞株においてmiR-34b添加時に細胞生存率の低下が認められた。また, HEC-1Bをヌードマウスの皮下に移植後, 28日目にはパクリタキセル+miR-34b群は他の群に比し有意に腫瘍径の縮小が認められた(P<0.05)。
microRNAs have key roles in the onset, development and drug resistance of cancer. We identified miR-34b as a tumor suppressor-type microRNA with expression that is epigenetically suppressed in endometrial cancer. In this study, the antitumor effect of combined miR-34b and antitumor drugs on endometrial cancer was examined. [Results] There was no change in cell viability after administration of miR-34b following application of cisplatin or adriamycin to HEC-108, HEC-1B and KLE cells. However, after treatment with paclitaxel, cell viability after administration of miR-34b decreased in all three cell lines. Tumor development occurred 14 days after transplantation of HEC-1B cells in nude mice. Drugs were administered on that day and thereafter. The tumor diameter significantly decreased in mice treated with paclitaxel + miR-34b compared with the results for other treatments (P<0.05). The GFP fluorescence signal also markedly decreased after treatment with paclitaxel + miR-34b.
|
|
Table of contents |
|
Keyword |
|
NDC |
|
Note |
研究種目 : 若手研究(B)
研究期間 : 2012~2014
課題番号 : 24791718
研究分野 : 婦人科腫瘍学
|
|
Language |
|
Type of resource |
|
Genre |
|
Text version |
|
Related DOI |
|
Access conditions |
|
Last modified date |
|
Creation date |
|
Registerd by |
|
History |
|
Index |
|
Related to |
|